American International Group Inc. Lowers Stock Position in The Clorox Company (NYSE:CLX)

American International Group Inc. cut its position in shares of The Clorox Company (NYSE:CLXFree Report) by 2.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 33,589 shares of the company’s stock after selling 683 shares during the quarter. American International Group Inc.’s holdings in Clorox were worth $4,789,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Fortitude Family Office LLC purchased a new position in Clorox during the fourth quarter valued at $29,000. Northwest Financial Advisors purchased a new position in Clorox during the fourth quarter valued at $29,000. Core Wealth Advisors Inc. purchased a new position in Clorox during the fourth quarter valued at $29,000. First United Bank & Trust purchased a new position in Clorox during the fourth quarter valued at $31,000. Finally, Tyler Stone Wealth Management lifted its holdings in Clorox by 64.5% during the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLX has been the topic of several recent analyst reports. Citigroup decreased their price objective on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. The Goldman Sachs Group started coverage on shares of Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price target on the stock. Wells Fargo & Company decreased their price target on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research note on Thursday, May 2nd. DA Davidson reissued a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Finally, Barclays decreased their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research note on Thursday, May 2nd. Four analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $146.43.

View Our Latest Research Report on Clorox

Clorox Price Performance

Clorox stock opened at $136.64 on Friday. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.14. The stock has a market cap of $16.97 billion, a P/E ratio of 70.80, a PEG ratio of 2.18 and a beta of 0.39. The company has a 50-day moving average price of $137.62 and a 200 day moving average price of $144.02. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the business earned $1.51 earnings per share. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. Sell-side analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current year.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.